Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/29/2012US20120301432 novel boswellia low polar gum resin extract and its synergistic compositions
11/29/2012US20120301431 Methods of treating a disease or condition associated with abnormal angiogenesis
11/29/2012US20120301430 Thiophene analogues for the treatment or prevention of flavivirus infections
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301428 Clostridium gene
11/29/2012US20120301427 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/29/2012US20120301425 Novel antitumoral use of cabazitaxel
11/29/2012US20120301424 Cyclodextrin-based polymers for therapeutics delivery
11/29/2012US20120301404 Treatment of cachexia
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012US20120301393 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
11/29/2012CA2837346A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
11/29/2012CA2837322A1 Cell and gene based methods to improve cardiac function
11/29/2012CA2837104A1 Amylin peptides and derivatives and uses thereof
11/29/2012CA2837096A1 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012CA2836847A1 Controlled release peptide formulations
11/29/2012CA2836799A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
11/29/2012CA2836503A1 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
11/29/2012CA2835816A1 Novel metalloprotein and process for producing same, and prophylactic or therapeutic agent for corneal and conjunctival diseases comprising said metalloprotein
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/29/2012CA2825333A1 Antagonism of the vip signaling pathway
11/28/2012EP2527837A1 Methods of inhibiting cell death or inflammation in a mammal
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527365A2 Proliferation of MUC1 expressing cells
11/28/2012EP2527360A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
11/28/2012EP2527008A2 Anticancerous polymeric agents
11/28/2012EP2526971A1 Mucosal delivery of drugs
11/28/2012EP2526968A2 Nogo receptor antagonists
11/28/2012EP2526962A1 Therapeutic application of Kazal-type serine protease inhibitors
11/28/2012EP2526961A1 Treating or ameliorating some neuroendocrine disorders in male with help of prolactin
11/28/2012EP2526960A1 Use of BV8 and/or EG-VEGF to promote hematopoiesis
11/28/2012EP2526959A1 Treatment of pulmonary disease conditions
11/28/2012EP2526958A1 Methods and compositions for the treatment of gastrointestinal disorders
11/28/2012EP2526957A2 Proliferation of MUC1 expressing cells
11/28/2012EP2526953A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526952A1 Methods and pharmaceutical compositions for healing wounds
11/28/2012EP2526942A2 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
11/28/2012EP2526939A1 Gelatine tannate and associations thereof for use in the treatment of inflammatory gastrointestinal diseases
11/28/2012EP2526774A2 Targeted gene delivery for dendritic cell vaccination
11/28/2012EP2526116A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen
11/28/2012EP2525833A2 Stable growth hormone compounds
11/28/2012EP2525823A1 Delivery system for diagnostic and therapeutic agents
11/28/2012EP2525810A1 Use of aprotinin for treating parasitic infections and prognosing bovine trypanotolerance
11/28/2012EP2525809A1 Treatment of cardiac conditions
11/28/2012EP2525808A2 Osteocalcin as a treatment for male reproductive disorders
11/28/2012EP2525807A1 Pharmaceutical composition for treating a metabolic syndrome
11/28/2012EP2525806A1 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
11/28/2012EP2525805A2 Oral care compositions and methods
11/28/2012EP2525804A1 Pan-antiviral peptides for protein kinase inhibition
11/28/2012EP2525779A2 Liquid formulations for long-acting erythropoietin conjugate
11/28/2012DE202012011016U1 Aflibercept-Spritze Aflibercept syringe
11/28/2012CN1989153B High affinity ny-eso t cell receptor
11/28/2012CN1895671B Compound preparation for treating viral liver disease
11/28/2012CN1620174B Cellular telecommunication system
11/28/2012CN102803954A Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy
11/28/2012CN102803487A Cancer antigen helper peptide
11/28/2012CN102802682A Wound-covering material
11/28/2012CN102802659A Use of LCAT for treating anemia and red blood cell dysfunction
11/28/2012CN102802658A Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
11/28/2012CN102802657A GLP-1 and FGF21 combinations for treatment of diabetes type 2
11/28/2012CN102802656A Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
11/28/2012CN102802655A Methods for reducing protein levels in a cell
11/28/2012CN102802654A Vaccine therapy for choroidal neovascularization
11/28/2012CN102802624A Nanodispersion Of A Drug And Process For Its Preparation
11/28/2012CN102802438A Method for reducing unpleasant taste
11/28/2012CN102796758A Recombinant porcine alpha interferon and application thereof in preparing medicines for treating Porcine cytomegalovirus (PCMV)
11/28/2012CN102796743A Improved IL-15 and IL-15R-alpha for expression in mammalian cells
11/28/2012CN102796741A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
11/28/2012CN102796201A Erythropoietin mimetic peptide (EMP)-human serum albumin (HSA) fusion protein and preparation method thereof
11/28/2012CN102796199A Fusion protein mutant of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein mutant and application of fusion protein mutant
11/28/2012CN102796198A Fusion protein of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein and application of fusion protein
11/28/2012CN102796197A Human serum albumin-granulocyte colony stimulating factor (HAS-GCSF) mutant and preparation method thereof
11/28/2012CN102796192A Human glucagon-like peptide-1 analogue
11/28/2012CN102796180A Specific basic fibroblast growth factor (bFGF) binding peptide
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796177A Transformed antibacterial peptide, preparation method and application
11/28/2012CN102796176A Kunyuenin, preparation method and application
11/28/2012CN102796171A Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796170A Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796169A Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof
11/28/2012CN102796168A Compounds with thrombolytic activity and preparation method and application thereof
11/28/2012CN102796167A (S)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine-6-formyl-L-prolyl-L-alanyl-L-amino acid, and preparation method and application thereof
11/28/2012CN102796166A Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof
11/28/2012CN102796165A Arg-Tyr modified aliphatic amine/ alcohol derivatives and preparation method and application thereof
11/28/2012CN102796164A Kyotorphin modified fatty amine/alcohol derivative, and preparation method and application thereof
11/28/2012CN102793922A Method for treating neoplastic disease in body of mammals
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102793911A Application of recombinant human Prx-6 protein to treatment of corneal injury
11/28/2012CN102793910A New application of casein kinase2-interacting protein-1 (CKIP-1) protein and coding gene thereof
11/28/2012CN102793688A Method for preparing lactase nanocapsules
11/28/2012CN102793667A Plutella xylostella antimicrobial peptide liposome, as well as preparation method and application thereof
11/28/2012CN102793663A Sustained-release microsphere injection containing antitumor drug (2-methoxyestradiol)
11/28/2012CN102793661A A liquid product of botulinum a-type toxin
11/28/2012CN102793632A Component for external use
11/28/2012CN102284062B Capsule shell composition for soft capsule containing ciclosporin, preparation method thereof and soft capsule containing ciclosporin prepared thereby
11/28/2012CN102268070B Substrate metal prolease-9 polypeptide inhibitor 2 and application thereof
11/28/2012CN102268069B Substrate metal prolease-9 polypeptide inhibitor 4 and application thereof
11/28/2012CN102091318B Toad peptide antibiotics separated from toad maggots and preparation method of antibacterial drugs thereof
11/28/2012CN102085361B Application of medicament containing hirudin and hementerin
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 3163